Zhejiang, China

Yongping Lu

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yongping Lu: Innovator in Indazole Derivatives

Introduction

Yongping Lu is a notable inventor based in Zhejiang, China. He has made significant contributions to the field of medicinal chemistry, particularly through his work on indazole derivatives. His innovative approach has led to advancements in therapeutic agents that target specific medical conditions.

Latest Patents

Yongping Lu holds a patent for an indazole amine derivative, which includes a preparation method and its medical use. The patent describes indazole derivatives represented by a specific formula, including their stereoisomers, tautomers, and pharmaceutically acceptable salts. These derivatives are particularly valuable as interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitors, showcasing their potential in treating various diseases.

Career Highlights

Lu is associated with Zhejiang Hisun Pharmaceutical Co., Ltd., where he has been instrumental in research and development. His work has not only contributed to the company's portfolio but has also advanced the field of pharmaceutical sciences. His dedication to innovation is evident in the quality and applicability of his research.

Collaborations

Yongping Lu has collaborated with notable colleagues, including Cheng Ye and Wenjian Qian. These partnerships have fostered a collaborative environment that enhances the research output and innovation at Zhejiang Hisun Pharmaceutical Co., Ltd.

Conclusion

Yongping Lu's contributions to the field of medicinal chemistry, particularly through his patent on indazole derivatives, highlight his role as a key innovator. His work continues to influence the development of therapeutic agents, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…